Related Experiment Video
Updated: Apr 6, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Facilitating collaboration in rare genetic disorders through effective matchmaking in DECIPHER
Eleni A Chatzimichali1, Simon Brent1, Benjamin Hutton1
1Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SD, United Kingdom.
DECIPHER is a platform for sharing genomic variant data from patients with genetic disorders. It aids in variant interpretation, diagnosis, and discovery of new syndromes by connecting researchers globally.
Area of Science:
- Genomic Medicine
- Clinical Genetics
- Bioinformatics
Background:
- Genetic disorders pose diagnostic challenges.
- Interpreting rare genomic variants requires extensive data and collaboration.
- Existing platforms may lack comprehensive tools for variant analysis and patient matching.
Purpose of the Study:
- To describe the features of the DECIPHER platform.
- To highlight tools aiding genomic variant interpretation and patient data sharing.
- To emphasize DECIPHER's role in accelerating rare disease diagnosis and discovery.
Main Methods:
- Secure deposition and analysis of genomic variants.
- Genotype-phenotype matching tools for patient identification.
- Facilitation of global collaboration among clinical centers and researchers.
Main Results:
- DECIPHER hosts data from over 51,500 patients.
- The platform has contributed to identifying new syndromes and disease genes.
- Over 700 peer-reviewed publications have resulted from DECIPHER data since 2004.
Conclusions:
- DECIPHER is an invaluable resource for clinical interpretation of genomic variants.
- The platform accelerates rare disease diagnosis through data sharing and matchmaking.
- DECIPHER fosters global collaboration, advancing clinical genetics research.
More Related Videos
09:37Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
Related Concept Videos
Sex Linked Disorders
Sex-linked Disorders
Animal Mitochondrial Genetics
Pharmacogenomics: Identification of New Drug Targets
Pedigree Analysis
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...